INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Volume And Viscosity Barriers In Biologic Formulations
Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.
-
Doubling Up For Speed In Biomanufacturing
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
Amorphous Solids: Implications For Solubility And Stability
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
-
Ask Us Anything: Miles Blackburn On Advances In Flow And Radical Chemistry
Miles Blackburn, Associate Director of Chemistry at Snapdragon Chemistry, on why the biggest payoff of flow and radical chemistry is speed — processes that scale fast enough to get intermediates and APIs delivered on a clinical timeline.
-
Get Smoother Separations, Faster: Troubleshoot Method Development6/18/2026
Strong chromatography requires more than separation. Fine-tuning pH, columns, and system volume prevents poor peak shape, while modeling tools streamline optimization for reproducible results.
-
Seed Train Intensification Using High Cell Density Cryopreservation8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return1/29/2026
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Evaluating Clone Performance And Cell-Specific Productivity8/6/2026
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
CMC (Chemistry, Manufacturing and Controls) Management6/26/2026
Eliminate regulatory risks caused by fragmented data. Learn how a continuous data thread from bench to batch streamlines tech transfer and accelerates filing timelines.
DRUG DEVELOPMENT SOLUTIONS
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.
-
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.
-
Optimize your cell line strategy for better viral vector production.